| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| P50 | author | You-Ping Li | Q88613535 |
| Yanni Zhou | Q96245518 | ||
| Li Feng | Q96245519 | ||
| P2093 | author name string | Dan Long | |
| Shengfu Li | |||
| Juan Shan | |||
| Yingjia Guo | |||
| P2860 | cites work | Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion | Q46834076 |
| Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival | Q47416460 | ||
| Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2. | Q47975868 | ||
| Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study. | Q50438028 | ||
| 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. | Q51391175 | ||
| Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. | Q51474550 | ||
| Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. | Q52019050 | ||
| Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. | Q53874628 | ||
| Semi-mature MyD88-silenced bone marrow dendritic cells prolong the allograft survival in a rat model of intestinal transplantation. | Q54385299 | ||
| Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells. | Q54655361 | ||
| Pretreatment of recipients with mitomycin-C-treated dendritic cells induces significant prolongation of cardiac allograft survival in mice. | Q54799376 | ||
| "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig | Q56901846 | ||
| Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells | Q56902358 | ||
| Abortive alloantigen presentation by donor dendritic cells leads to donor-specific tolerance: a study with a preoperative CTLA4lg inoculation | Q56906477 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| Adoptive infusion of tolerogenic dendritic cells prolongs the survival of pancreatic islet allografts: a systematic review of 13 mouse and rat studies | Q28484410 | ||
| Donor antigen-loaded IKK2dn gene-modified dendritic cells prolong allograft survival | Q28576467 | ||
| Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates | Q33804736 | ||
| Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. | Q34193317 | ||
| Variation and genetic control of gene expression in primary immunocytes across inbred mouse strains | Q34364719 | ||
| Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
| Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes | Q35605392 | ||
| Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. | Q37077325 | ||
| Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells | Q37262385 | ||
| AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews | Q37397185 | ||
| Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? | Q37945301 | ||
| Cell therapy using tolerogenic dendritic cells in transplantation | Q38078105 | ||
| Adoptive transfusion of tolerance dendritic cells prolongs the survival of cardiac allograft: a systematic review of 44 basic studies in mice | Q38106725 | ||
| Adoptive transfusion of tolerance dendritic cells prolongs the survival of skin allografts in mice: a systematic review | Q38119559 | ||
| Adoptive infusion of tolerance dendritic cells prolongs survival of small intestine allografts in rats: systematic review and meta-analysis | Q38170153 | ||
| Adoptive transfusion of tolerant dendritic cells prolong the survival of renal allografts: a systematic review | Q38170168 | ||
| Adoptive transfusion of tolerogenic dendritic cells prolongs the survival of liver allograft: a systematic review | Q38243159 | ||
| Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig | Q38363193 | ||
| Immature CD4⁺ dendritic cells conditioned with donor kidney antigen prolong renal allograft survival in rats. | Q39571198 | ||
| A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival | Q40882028 | ||
| IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses and promote immunological tolerance in diabetes | Q41279486 | ||
| Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival | Q41882308 | ||
| Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival | Q43034429 | ||
| Tetrandrine attenuates dendritic cell-mediated alloimmune responses and prolongs graft survival in mice | Q43148662 | ||
| Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival | Q44074328 | ||
| Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. | Q44645237 | ||
| Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival? | Q45160820 | ||
| Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival | Q45219593 | ||
| Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells | Q45229049 | ||
| Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice | Q45337343 | ||
| Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection | Q45858420 | ||
| Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells | Q46187803 | ||
| Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections | Q46422409 | ||
| CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice | Q46454884 | ||
| The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients | Q46608787 | ||
| Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients | Q57221897 | ||
| [Effects of TGF-beta1, gene modified donor dendritic cells on immune repulsion] | Q64377453 | ||
| Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival | Q73045866 | ||
| CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection | Q73128939 | ||
| Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival | Q73289641 | ||
| Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells | Q73340528 | ||
| Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells | Q73438405 | ||
| Does intrathymic injection of alloantigen-presenting cells before islet allo-transplantation prolong graft survival? | Q73677770 | ||
| Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
| Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells | Q74415746 | ||
| Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts | Q77373891 | ||
| Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells | Q79767145 | ||
| Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells | Q80118079 | ||
| [Immune tolerance induced by IL-10 and methylprednisolone modified dendritic cells in vitro] | Q80292204 | ||
| [Study on the induction of skin transplantation tolerance against rejection in mice by third-party dendritic cells loaded with donor's antigens] | Q81216865 | ||
| Induction of peripheral tolerance by local delivery of dendritic cell progenitors to cardiac allografts in a murine heterotopic heart transplantation model | Q81292276 | ||
| Prolonged survival of donor-specific rat intestinal allograft by administration of bone-marrow-derived immature dendritic cells | Q81621220 | ||
| Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression | Q81681979 | ||
| [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival] | Q82087780 | ||
| Organ-specific differences in acute rejection intensity in a multivisceral transplant | Q82374678 | ||
| Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death | Q82414512 | ||
| Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models | Q82588351 | ||
| Rapamycin combined with donor immature dendritic cells promotes liver allograft survival in association with CD4(+) CD25(+) Foxp3(+) regulatory T cell expansion | Q82612132 | ||
| Mechanism of immune hyporesponsiveness induced by recipient- derived immature dendritic cells in liver transplantation rat | Q83876277 | ||
| Immune tolerance induced by RelB short-hairpin RNA interference dendritic cells in liver transplantation | Q85573321 | ||
| Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance | Q85635037 | ||
| DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells | Q88222745 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| dendritic cell | Q506253 | ||
| immune tolerance | Q1356761 | ||
| systematic review | Q1504425 | ||
| biomedical investigative technique | Q66648976 | ||
| organ transplantation | Q69253852 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | 5730674 | |
| P577 | publication date | 2016-07-28 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews | |
| P478 | volume | 2016 |
| Q97644521 | Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer |
| Q90185646 | Impact of infection on transplantation tolerance |
| Q97519150 | Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies |
| Q50177437 | Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies. |
| Q50993283 | Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells. |
| Q57790413 | Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation |
| Q58785770 | The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis |
| Q39013872 | Tolerogenic dendritic cell therapy in organ transplantation |
Search more.